Searching for clues: why some melanoma patients beat the odds with immunotherapy
NCT ID NCT07302607
Summary
This study looks back at medical records of 221 patients with advanced melanoma who received immunotherapy between 2013 and 2021. Researchers want to understand what patient or disease characteristics might predict who achieves a complete response, where all signs of cancer disappear. The goal is to identify new factors that could help doctors better predict treatment success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de dermatologie - Réanimation - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.